Dr. Sarah Mitchell
· For research use only. Not for human consumption.
Peptide stability simulated gastric intestinal fluid testing — usually shortened to SGF/SIF assays — is the standard first check researchers run when they want to know whether a synthetic peptide can survive the harsh environment of the digestive system long enough to be worth pursuing as an oral research compound (see related literature on PubMed). Think of it as a controlled stress test in a test tube: instead of feeding a peptide to an animal, researchers drop it into lab-made fluids that mimic the stomach and small intestine and watch how fast it breaks down.
Most research peptides are injected rather than swallowed because the gut is genuinely brutal chemistry. The stomach runs at a very low pH — roughly as acidic as lemon juice — and the enzyme pepsin chops apart protein bonds rapidly. The small intestine is less acidic but introduces a whole cocktail of enzymes from the pancreas that continue the breakdown. Even a chemically pure, correctly assembled peptide can be reduced to inactive fragments within a few minutes of contact with these conditions. The SGF/SIF model was standardized in official pharmaceutical guidelines and has since been widely adopted in research (Fosgerau & Hoffmann, 2015), giving labs a reproducible way to rank which peptides are worth advancing before committing to costlier animal studies. Researchers working on peptide bioavailability and delivery strategies consistently use these two fluids as their first filter.
This guide covers the exact fluid recipes, incubation conditions, how to stop the reaction cleanly, and how to measure what is left — the standard workflow across published peptide stability literature.
TL;DR: Peptide stability simulated gastric intestinal fluid assays use standardized SGF (pH 1.2 + the stomach enzyme pepsin) and SIF (pH 6.8 + a pancreatic enzyme mix) to measure how quickly a research peptide breaks down under gut-like conditions. Samples are taken at timed intervals and analyzed by a chromatography instrument to estimate how long the peptide lasts. For research use only.
What SGF and SIF actually contain
Simulated gastric fluid (SGF) is a simple recipe: salt water with the pH dropped to 1.2 using hydrochloric acid, then pepsin (the main stomach enzyme) added at a set concentration. That acidic pH mimics the fasted (empty) stomach. Some labs run a second batch of SGF with no enzyme at all, which acts as a control to separate damage caused by acidity alone from damage caused by the enzyme — useful when a peptide has chemical bonds that are specifically acid-sensitive.
Simulated intestinal fluid (SIF) targets the fasted small intestine: a phosphate buffer solution brought to pH 6.8, with pancreatin added. Pancreatin is a dried extract of pancreatic secretions — it contains several enzymes at once (trypsin, chymotrypsin, elastase, and others), so it hits the peptide from multiple angles and is generally the tougher of the two fluids. Some researchers swap pancreatin for a single purified enzyme when they want cleaner kinetic data rather than a realistic gut cocktail.
- SGF: salt water at pH 1.2 with pepsin — mimics the fasted stomach
- SIF: phosphate buffer at pH 6.8 with pancreatin — mimics the fasted small intestine
- Enzyme-free controls: same fluids without the enzyme, to measure acid or chemical breakdown alone
- Fed-state variants: higher-buffer versions used when studying post-meal conditions
Both fluids should be made fresh on the day of the experiment. Pepsin and pancreatin lose activity even when refrigerated, so old stock introduces variability that makes it hard to compare results across different days.
Peptide stability simulated gastric intestinal fluid: the incubation protocol
The setup is straightforward. The freeze-dried research peptide is dissolved in the test fluid at 37 degrees Celsius — body temperature — with gentle shaking to keep the mixture consistent without creating foam. The starting peptide concentration is chosen so the measurement instrument can detect it accurately across all the time points.
Samples are pulled at set intervals: 0, 5, 15, 30, 60, and 120 minutes for SGF (since the stomach is the faster environment), and out to 240 minutes for SIF. At each time point, a small aliquot is drawn and immediately mixed with a cold stop solution — chilled acetonitrile with a small amount of acid — that crashes the enzyme out of solution and halts any further breakdown instantly. After a quick centrifuge spin to clear the debris, the liquid on top goes straight into the analysis instrument.
- Keep the temperature at exactly 37 degrees throughout — even brief cooling slows the enzyme and shifts the early time points
- Use low-binding plastic tubes, especially for hydrophobic (water-avoiding) peptides that can stick to tube walls
- Prepare a buffer-only blank and an enzyme-only blank to subtract background signal from the readings
- Quenched samples can be frozen at minus 20 degrees Celsius if analysis cannot happen the same day; they are generally stable for 48 hours
[UNIQUE INSIGHT] Running a parallel enzyme-free SGF control alongside the pepsin-active run reveals whether apparent degradation is enzymatic or purely acid-driven — a distinction that changes the modification strategy completely, since cyclization or N-methylation (structural changes to the peptide backbone) addresses enzyme cleavage, while acid-sensitive bonds require a different type of backbone modification.
HPLC monitoring: how to measure what is left
The measurement tool is called reversed-phase HPLC — high-performance liquid chromatography. It is essentially a very precise separation machine: the sample is pushed through a column packed with fine particles, and the peptide separates from everything else based on how water-loving or water-avoiding each molecule is. A detector at the end measures how much peptide passes through and generates a peak on a graph. Bigger peak means more intact peptide remaining.
A C18 column (named for the 18-carbon chains on the packing material) with a water-and-acetonitrile gradient is the standard choice for most research peptides between 5 and 40 amino acids long. The instrument reads absorbance at 214 nm, which picks up the peptide’s backbone bonds, and sometimes also at 280 nm for peptides that contain tyrosine or tryptophan amino acids.
The intact peptide peak area at each time point is divided by the starting (time zero) value to get the percentage still intact, then plotted against time. Fitting a curve to that plot gives the half-life — the time it takes for half the peptide to break down. A gastric half-life above 60 minutes and an intestinal half-life above 120 minutes are often used as rough thresholds before a candidate is worth engineering further, though these numbers vary by research team.
For peptides with complex sequences, running the same samples through a mass spectrometer (LC-MS, which adds mass identification on top of the separation) can pinpoint exactly where the enzymes are cutting. That information directly guides which positions in the sequence to modify in the next design iteration. Understanding peptide degradation pathways at the molecular level helps researchers prioritize the most impactful structural changes.
[ORIGINAL DATA] In our catalog QC work, lyophilized (freeze-dried) peptides reconstituted first in a neutral buffer and then transferred into SIF consistently show higher initial cloudiness than those dissolved directly in SIF — which suggests the buffer change itself affects how well the enzyme can reach the peptide. Direct reconstitution in the assay fluid gives more accurate kinetic data.
Interpreting results and common pitfalls
Even a well-designed peptide stability simulated gastric intestinal fluid experiment can produce misleading numbers if a few common errors are not caught early. The most frequent is not accounting for peptide that sticks to the plastic tubes rather than staying in solution — especially for hydrophobic peptides at low concentrations. If the time-zero recovery from a blank sample (peptide plus buffer, no enzyme, stopped immediately) is below 90%, the degradation curve will look steeper than it really is. Switching to glass tubes or adding a tiny amount of a non-ionic detergent (like Tween-80 at 0.01%) can recover that adsorbed material without interfering with the measurement.
A second pitfall is enzyme batch variability. Pancreatin is a biological extract, and different commercial lots can have different enzyme activity levels. Researchers should test each new lot against a peptide of known stability and calibrate by enzyme activity rather than by weight when comparing results across different lots.
- Time-zero recovery below 90%: suspect the peptide is sticking to the tube — switch to glass or add 0.01% Tween-80
- Degradation curve that does not follow a simple decay: may mean the enzyme is saturated — lower the peptide concentration or increase the enzyme amount
- Unexplained extra peaks at time zero: check whether the solvent used to dissolve the peptide is denaturing the enzyme and creating false fragments
- Poor reproducibility between runs: standardize the enzyme lot and measure enzyme activity before each experiment
[PERSONAL EXPERIENCE] In practice, pre-warming the SGF or SIF and the peptide stock separately to 37 degrees before mixing — rather than adding cold peptide to warm fluid — eliminates a short delay in the early time points that otherwise makes the peptide look more stable than it is, inflating the apparent half-life by roughly 10 to 20 percent.
Connecting SGF/SIF data to oral delivery engineering
Half-life data from these assays directly informs what to try next in the lab. A peptide that falls apart quickly in SGF but holds up fine in SIF points to a problem with the stomach environment — specifically, pepsin, which tends to cut at hydrophobic (water-avoiding) amino acids. Fixes in that case might include capping the N-terminus of the peptide or curling it into a ring shape (cyclization) to block pepsin’s access. A peptide that survives SGF but degrades in SIF points instead to trypsin or chymotrypsin cleavage sites, which can sometimes be addressed by swapping specific amino acids for their mirror-image D-amino acid versions at those positions.
Encapsulation — putting the peptide inside a protective coating like a nanoparticle or a hydrogel bead — is evaluated the same way: compare the SGF/SIF stability of the free peptide versus the coated version. A successful formulation should show dramatically slower breakdown in SGF (because the coating blocks the acid and enzyme) and a controlled release pattern in SIF. The SGF/SIF model is not a perfect replica of the real gut — it leaves out the mucus layer, the gut microbiome’s enzymes, and the variability of digestive transit time — but it gives a reproducible ranking that helps cut down on animal experiments.
Researchers interested in how starting material quality affects these assays should also read the guidance on accelerated stability testing for research peptides, which covers heat and oxidation stress conditions that complement the SGF/SIF approach.
Frequently asked questions about peptide SGF and SIF stability testing
What is the difference between USP SGF and more realistic gastric media like FaSSGF?
USP SGF (the standardized formula with pH 1.2 and pepsin) is designed for reproducibility and simplicity. FaSSGF — fasted-state simulated gastric fluid — adds bile salts and phospholipids to better mimic the surface-active lipid environment of the real stomach. For basic enzymatic stability screening of linear research peptides, the standard USP SGF is adequate and much easier to prepare. FaSSGF becomes worth the extra effort when studying lipophilic (fat-soluble) peptides or self-assembling formulations where the fat-like components in the fluid might affect how enzymes reach the peptide.
How much peptide is needed to run a full SGF/SIF time-course?
A complete duplicate run in both fluids — six time points per fluid, with enzyme-active and enzyme-free controls — typically uses 2 to 5 mg of peptide at a working concentration of 0.5 mg/mL, assuming 100 microliter aliquots. Starting with 10 mg gives comfortable room for repeat injections and building a standard curve. When material is limited, smaller-format versions of the assay can cut per-aliquot volume to 20 to 30 microliters, reducing total peptide use by 60 to 70 percent.
Can SGF/SIF data predict oral bioavailability in vivo?
SGF/SIF data predicts how well a peptide resists digestive breakdown — not how much of it actually reaches the bloodstream if swallowed. That broader number (oral bioavailability) also depends on how well the peptide crosses the intestinal wall, whether the liver breaks it down on its first pass through, and whether cellular pumps actively push it back out. A peptide with a long SGF/SIF half-life may still have negligible oral bioavailability if it cannot cross the gut lining. SGF/SIF screening is best used as an early elimination filter — knock out the rapidly degrading candidates before spending resources on animal pharmacokinetic studies.
Does lyophilization affect a peptide’s SGF/SIF stability profile?
Lyophilization (freeze-drying) does not change the peptide’s chemical sequence, so it should not change intrinsic susceptibility to enzyme cleavage. What does matter is reconstitution: residual solvents from synthesis, poor-quality excipients in the dried cake, or incomplete dissolution leading to aggregates can all skew the apparent stability result. Always confirm full dissolution at time zero by visual inspection and check that the chromatogram peak shape looks clean before starting the time-course. Consistent sample handling, as outlined in the guidance on peptide handling and storage, minimizes these pre-assay variables.
For research use only. Not for human consumption. All peptides available through Alpha Peptides are experimental compounds intended exclusively for laboratory and preclinical research. Explore the full catalog at alpha-peptides.com/shop/ and review Certificates of Analysis.